161 related articles for article (PubMed ID: 20045755)
1. Effect of estrogen on the activity and growth of human osteoclasts in vitro.
Chen FP; Wang KC; Huang JD
Taiwan J Obstet Gynecol; 2009 Dec; 48(4):350-5. PubMed ID: 20045755
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of osteoclast differentiation by daidzein via caspase 3.
Rassi CM; Lieberherr M; Chaumaz G; Pointillart A; Cournot G
J Bone Miner Res; 2002 Apr; 17(4):630-8. PubMed ID: 11918220
[TBL] [Abstract][Full Text] [Related]
4. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
5. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro.
Qu Q; Härkönen PL; Mönkkönen J; Väänänen HK
Bone; 1999 Aug; 25(2):211-5. PubMed ID: 10456387
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
7. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media.
Costa-Rodrigues J; Teixeira CA; Sampaio P; Fernandes MH
J Cell Biochem; 2010 Jan; 109(1):205-16. PubMed ID: 19911374
[TBL] [Abstract][Full Text] [Related]
9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
10. Formation of osteoclasts on calcium phosphate bone cements and polystyrene depends on monocyte isolation conditions.
Bernhardt A; Schumacher M; Gelinsky M
Tissue Eng Part C Methods; 2015 Feb; 21(2):160-70. PubMed ID: 24919531
[TBL] [Abstract][Full Text] [Related]
11. Rodent osteoblast-like cells support osteoclastic differentiation of human cord blood monocytes in the presence of M-CSF and 1,25 dihydroxyvitamin D3.
Quinn JM; Fujikawa Y; McGee JO; Athanasou NA
Int J Biochem Cell Biol; 1997 Jan; 29(1):173-9. PubMed ID: 9076952
[TBL] [Abstract][Full Text] [Related]
12. Estrogen inhibition of PTH-stimulated osteoclast formation and attachment in vitro: involvement of both PKA and PKC.
Liu BY; Wu PW; Bringhurst FR; Wang JT
Endocrinology; 2002 Feb; 143(2):627-35. PubMed ID: 11796519
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
[TBL] [Abstract][Full Text] [Related]
14. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
[TBL] [Abstract][Full Text] [Related]
15. 17Beta-estradiol antagonizes effects of 1alpha,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures.
Schiller C; Gruber R; Redlich K; Ho GM; Katzgraber F; Willheim M; Pietschmann P; Peterlik M
Endocrinology; 1997 Nov; 138(11):4567-71. PubMed ID: 9348179
[TBL] [Abstract][Full Text] [Related]
16. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
17. The human osteoclast precursor circulates in the monocyte fraction.
Fujikawa Y; Quinn JM; Sabokbar A; McGee JO; Athanasou NA
Endocrinology; 1996 Sep; 137(9):4058-60. PubMed ID: 8756585
[TBL] [Abstract][Full Text] [Related]
18. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
Evans CE; Mylchreest S; Andrew JG
BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of monocytes into multinucleated giant bone-resorbing cells: two-step differentiation induced by nurse-like cells and cytokines.
Toyosaki-Maeda T; Takano H; Tomita T; Tsuruta Y; Maeda-Tanimura M; Shimaoka Y; Takahashi T; Itoh T; Suzuki R; Ochi T
Arthritis Res; 2001; 3(5):306-10. PubMed ID: 11549372
[TBL] [Abstract][Full Text] [Related]
20. Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts.
Sørensen MG; Henriksen K; Dziegiel MH; Tankó LB; Karsdal MA
DNA Cell Biol; 2006 Aug; 25(8):475-83. PubMed ID: 16907645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
